PAP 2023: Corey Ford Discusses State of the Industry Presentation at Access PAP 2023

Panel discussion addresses how DE&I can successfully tackle systemic biases and more.

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

A panel uncovers the value in meeting carbon-neutral goals by 2030.

Panel discussion uncovers how to alter one’s digital know-how for use in temperature-controlled supply chain.

Masterclass session addresses looking beyond a dashboard by added capabilities with added value.

A cohort study digs into whether there is an improvement in overall survival or quality of life within five years of the FDA granting accelerated approval to oncology drugs.